Identification of the Molecular Basis of Nanocurcumin-Induced Telocyte Preservation within the Colon of Ulcerative Colitis Rat Model

Arafat, Eetmad A.; Marzouk, Rehab Elsayed; Mostafa, Sally Abdallah; Hamed, Walaa H. E.

doi:https://doi.org/10.1155/2021/7534601

Mediators of Inflammation

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Ethical Approval Conflicts of Interest References Copyright Related Articles

Special Issue

Gastrointestinal Minimal Inflammation in Functional Gastrointestinal Disorders and Liver Metabolism

View this Special Issue

Research Article | Open Access

Volume 2021 | Article ID 7534601 | https://doi.org/10.1155/2021/7534601

Identification of the Molecular Basis of Nanocurcumin-Induced Telocyte Preservation within the Colon of Ulcerative Colitis Rat Model

Eetmad A. Arafat,¹Rehab Elsayed Marzouk,²Sally Abdallah Mostafa,²and Walaa H. E. Hamed¹

Academic Editor: Hirokazu Fukui

Received24 Apr 2021

Revised10 Jun 2021

Accepted25 Jun 2021

Published31 Jul 2021

Abstract

Background. Telocytes (TCs) are a distinct type of interstitial cells that play a vital role in the pathogenesis of ulcerative colitis and colonic tissue hemostasis. The aim of this study was to examine the effect of nanocurcumin (NC) on the morphometric and immunohistochemical characterization of TCs in the ulcerative colitis (UC) rat model. Methods. Forty rats were randomly divided into control, NC, UC, and UC+NC groups. At the end of the experiment, the colon was dissected and prepared for histopathological and immunohistochemical assessment. Tissue homogenates were prepared for real-time PCR assessment of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and transforming growth factor-beta (TGF-β) gene expression. Our results revealed extensive mucosal damage with inflammatory cell infiltration, significant reduction of CD34, and vimentin immunostained TCs in the colon of the UC group with significant elevation of expression of IL-6, TNF-α, and TGF-β. The UC+NC-treated group revealed significant elevation of TC count compared to the UC group besides, a significant reduction of the three gene expression. Conclusion. NC successfully targeted the colonic tissue, improved the mucosal lesion, preserve TCs distribution, and count through its anti-inflammatory and fibrinolytic properties.

1. Introduction

Ulcerative colitis (UC) is a subtype of inflammatory bowel disease (IBD), frequently affecting the rectum and left colon [1]. Although it has been shown that hereditary, immunological, and environmental elements are involved in the pathogenesis of UC, the specific etiology of the disease remains unknown [2]. Certain key roles involved within the signaling pathway in the development of IBD are performed via molecular mechanisms that are not yet fully understood [3].

There is growing evidence that cytokine production plays an important role in IBD. The pathological characteristics of the disease include increased inflammatory cell infiltration and proinflammatory mediators such as tumor necrosis factor-alpha (TNF-α) and interleukins, in addition to an excessive release of reactive oxygen species and reactive nitrogen species with loss of antioxidant abilities of the colon and mucosal continuity [4].

One of the first-line treatments for UC is anti-inflammatory drugs, including corticosteroids and aminosalicylates. Despite their high effectiveness, these drugs have extensive side effects [5]. Thus, a more reliable and less risky anti-inflammatory treatment is needed.

Disturbed colonic motility is well established in patients with UC, and dysmotility has been associated with changes in the enteric neuromuscular compartment secondary to the fibrotic colon as well as the destruction of interstitial cells [6].

Telocytes (TCs) are a distinct subset of interstitial cells characterized by small cell bodies and relatively long and thin extensions called telopodes (Tps) [5, 7–9]. TCs were shown to occupy a strategic position in relation to stem cell niches and precursor stem cells [8]. In the colon, they form a subepithelial reticular network that is present under the intestinal crypts, and they are involved in supporting the stem cell niche of this region [10]. TCs are also thought to play a major role in tissue repair/regeneration, in addition to forming intercellular networks within the muscularis externa, which consequently supports peristaltic movements [11].

TCs and their Tps were identified in close contact with other TCs via direct cell-to-cell connections, stem cells, inflammatory cells, nerves, the microvasculature, immune cells, and noncellular elements, such as collagen and elastic fibers [11].

The lamina propria of the gut contains TCs exhibiting differential upregulation of IL-6 and IL-10, which are thought to be involved in many autoimmune and inflammatory diseases [12].

Curcumin is a natural spice and food coloring herb that is frequently used in traditional medicine. Several previous studies have shown that curcumin extract from turmeric rhizomes has anti-inflammatory, antioxidant, anticancer, antimicrobial, and wound healing properties [13]. However, the primary restriction of its medicinal use is that curcumin is extremely hydrophobic with poor water solubility. Therefore, it exhibits poor absorption from the gastrointestinal tract and low bioavailability following oral intake [14]. Several studies have been conducted to improve the oral bioavailability of curcumin. Nanotechnology was indicated as one of the most effective methods to enhance the bioavailability of curcumin after oral administration, which was 30-fold higher than that of powder form in both rats and humans [15].

Although the anti-inflammatory and fibrinolytic properties of nanocurcumin are well established, there is no sufficient molecular or cellular basis for its impact on the organization and morphometric or immunohistochemical characterization of TCs. To the best of our knowledge, this is the first basic research conducted upon nanoparticle curcumin investigating the morphometric analysis of TCs in an UC model.

2. Materials and Methods

2.1. Preparation of Curcumin Nanoparticles

The hydrothermal squeezing method was implemented for the preparation of curcumin nanoparticle extract. A total of 10 g of nature-made turmeric curcumin powder (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in a 100 ml saline solution containing 2% Tween 80 in a 200 ml Teflon beaker. It was then autoclaved at 40°C overnight for approximately 24 h. Curcumin nanoparticles were squeezed from the powder and suspended within the solution under the effect of temperature and pressure in the closed autoclave. The obtained suspension was then diluted to a precalculated concentration for administration. The stock solution was stored in a cold dark place until use [16].

Nanoparticles were characterized using a transmission electron microscope and Fourier-transform infrared (FTIR) spectroscopy in the wavenumber range of 400–4000 cm−1 and accuracy of 1.0 cm−1 (Tensor 27, Brucker, Germany).

2.2. Experimental Animals

Forty adult male Wistar rats (weight, 120–150 g; 8–10 weeks old) were obtained from the Animal House, Faculty of Pharmacy, Mansoura University. Rats were housed in sanitary well-ventilated steel cages (two rats per cage). They were left to acclimatize for 1 week before beginning the experiment. Animals were fed ad libitum under standard laboratory conditions with 12 h light/dark cycles and a temperature-controlled environment ().

2.3. Experimental Induction of the UC Model

One day before the induction of colitis, rats were starved but allowed free access to drinking water. After light ether anesthesia, acute colitis was performed through intrarectal administration of 1 ml of 4% acetic acid solution (AA) (Sigma-Aldrich) via a soft silicone catheter, and then 2 ml of air was injected in the catheter to allow the colonic spread of AA. Lastly, rats were held straight for 2 min to avoid any leakage from the anus [17, 18].

2.4. Experimental Design

A larger sample size than that estimated from the “resource equation” method was used to overcome predictable animal deaths from UC or the experimental techniques.

Rats were divided into four groups (10 rats each). The control group (negative control) each received a single intrarectal administration of 2 ml saline. NC-treated group (the positive control) each received 100 mg/kg nanocurcumin orally through a gastric tube daily for 2 weeks.

The ulcerative colitis group (UC group) included ten rats that underwent induction of UC via intrarectal injection of 2 ml 4% AA as described above. UC+NC group included ten rats that underwent induction of UC and received daily oral gavage of 100 mg/kg nanocurcumin for 2 weeks [19].

2.5. Tissue Sampling and Staining

Following 24 h from the end of experiment, all rats from the four groups were euthanized via intraperitoneal injection of sodium pentobarbital anesthesia (50 mg/kg). The abdomen was dissected, and the left colon was divided into three segments, followed by fixation of one segment from each animal in 10% buffered formalin overnight for preparation of paraffin blocks. A rotatory microtome was used to obtain 5 μm-thick sections to stain as follows: hematoxylin and eosin (H&E) for histological evaluation, Masson’s trichrome staining for evaluation of fibrous tissue, and immunohistochemical staining with CD34 and vimentin for identification of TCs.

Another colon segment was fixed in glutaraldehyde and osmic acid for capsule preparation, and semithin sections stained with toluidine blue were obtained.

The final segments were immediately submerged in RNA later (Qiagen, Germany), incubated at 4°C overnight or longer, followed by total RNA extraction the next day.

2.6. Immunohistochemical Study

Paraffin sections (5 μm thick) mounted on positively charged glass slides were deparaffinized and hydrated. Endogenous peroxidase activity was blocked by immersing the slides in 10% H2O2. The antigenic sites were unmasked by submerging the sections in 0.001 mol (M) citrate buffer () followed by boiling in a microwave for 5 min. Nonspecific staining of the slide background was avoided by incubating the slides with 1/100 normal rabbit serum for 20 min. Slides were then washed in 0.1 M phosphate-buffered saline (PBS) for 5 min. Diluted primary antibodies, including anti-CD34 (polyclonal, 1 : 100, Product# PA5-78978, Thermo Fisher Scientific) and rat polyclonal Vimentin (1 : 100; Cat #PA5-27231, Thermo Fisher Scientific), were then added to the slides for 1 h followed by washing with PBS. a secondary antibody (1 : 2000, Vector Laboratories) was added to the slides for 10 min. Avidin–biotin–peroxidase complex (Vector, Burlingame, CA) was applied for 30 min to visualize the site of immunostaining reaction, while 3,3-diaminobenzidine was administered for 10 min as a chromogen. Lastly, Mayer’s Hematoxylin was used as a counterstain. Negative control sections were generated as outlined above with replacement of the 1ry antibodies with phosphate-buffered saline. The capillary endothelium and tonsil tissues were sectioned and stained as positive controls for CD34 and Vimentin, respectively.

2.7. Morphometric Study

Quantitative assessment of CD34- and vimentin-positive TCs was performed on colonic sections immunologically stained with anti-CD34 and antivimentin antibodies using a CX31 light microscope (Olympus, Japan) connected with Leica Qwin 500 image analyzer computer system (Leica, England). Serial sections were obtained from the colon of each rat (6 rats|group), and 5 slides were selected from each rat (one|ten serial sections). Sections were examined at 400X. The examined fields included the mucosa, submucosa, circular muscle layer, myenteric plexus, and longitudinal muscle layer. Counting was conducted manually, including only all the cells with definite nuclei. The area percentage of collagen fibers was measured using five slides for each rat at 250X.

2.8. Biochemical Study

Determination of IL-6, TNF-α, and TGF-B genes expression by real-time PCR (RT-qPCR).

RNA purification was performed using TRIzol reagent (Invitrogen, USA). Complementary DNA was then synthesized using Thermo Scientific Maxima First Strand cDNA Synthesis Kit with dsDNase (Thermo Fisher Scientific, Rockford, USA).

Primer sets for genes were designed using the Primer3PLUS software (v. 0.4.0; http://frodo.wi.mit.edu/; Table 1). Real-time PCR assays were performed using the Applied Biosystem 7500 real-time PCR detection system (Life Technologies, USA) according to the method described [20] with the SensiFAST SYBR Lo-ROX PCR Master Mix Kit (Bioline, United Kingdom). The total reaction volume was 20 μl, and the thermal reaction profile was as follows: initial denaturation at 95°C for 2 min and then 40 cycles of 95°C for 5 s followed by 60°C for 30 s. Calculation of fold change of gene expression was normalized to β–actin according to cycle threshold (Ct) method (2^-ΔΔCt). The relative gene expression for all genes was normalized to one in the control group (negative control) [21].

2.9. Statistical Analysis

Morphometric and molecular results were statistically analyzed using the Statistical Package for the Social Sciences software (version 21). Data are presented as , and values < 0.05 represent significant differences.

3. Results

3.1. Characterization of Curcumin Nanoparticles

Transmission electron microscopic study of curcumin nanoparticles used in this study revealed an average nanoscale diameter less than 50 nm (Figure 1). FTIR spectrum analysis revealed numerous absorption bands indicative of the presence of curcumin (Figure 2).

(a)

(b)

3.2. Histopathologic and Morphometric Results

3.2.1. (H&E) Staining Results

H&E-stained sections of the control group colon sections exhibited the same histological picture in both the control and NC groups. Colons consisted of a normal histological arrangement of the four layers of the tissue wall: mucosa, submucosa, muscularis externa, and serosa. The mucosa consisted of regularly arranged, closely backed intestinal crypts lined by columnar absorptive cells with abundant goblet cells. A thin layer of lamina propria with few lymphocytes was observed, as well as TCs in sections presenting as spindle shape cells with long Tps. These cells were noted to form a network around the crypts in the lamina propria, in the submucosa, and in between the muscle fibers. The control group (Figures 3(a)–3(d)) NC group (Figures 3(e)–3(h)).

Figure 3

Photomicrographs of H&E-stained sections in the colon. (a–d) The control group and (e-h) NC group both show the normal structure of the colon; the mucosa (M), submucosa (SM), musculosa (Ms), and serosa (double arrowheads). The mucosa has regularly arranged closely backed tubular crypts (C) the crypts lines by simple columnar absorptive cells (arrow) with numerous goblet cells (arrowhead). The surface shows intact surface epithelium, and the glands are resting on a thin layer of muscularis mucosa. A thin layer of lamina propria containing numerous lymphocytes is present between crypts. (i–l) The ulcerative colitis group reveals loss of normal mucosal architecture, disturbed crypts (star), loss of surface epithelium and goblet cells (arrow), dilated congested blood vessels (lined arrow), and areas of mucosal ulceration (arrow) with thickening of the underling muscularis mucosa (curved arrows). The submucosa is wide with thick dilated blood vessels (BV). Inflammatory cell infiltration (IFC) is obvious in the mucosa and submucosa. The musculosa reveals separation between muscle bundle (tailed arrow), inflammatory cell infiltration (crossed arrow), and myenteric plexus (right-angled arrow). (m–p) The UC+NC group shows the normal architecture of the colon apart from narrow areas of interrupted surface epithelium (arrow). Note: telocytes appear as spindle shape cells (thick arrow) with small flat nuclei and long telopodes (wavy arrow). (H&E, (a, e, i, and m) X100, (b, c, d, f, g, h, j, k, l, n, o, and p) X400 insert in b, j, and n X1000).

Histological examination of H&E-stained sections from the UC group revealed extensive mucosal damage in the form of loss of columnar absorptive epithelium lining the surface, few crypts with few goblet cells, heavy infiltration with inflammatory cells, and numerous congested blood vessels with areas of hemorrhagic lesions. Other areas with complete loss of mucosal glands and hypertrophy of the underlying muscularis mucosa were observed. The submucosa revealed diffuse mononuclear cellular infiltration, submucosal edema, and an obvious increase in submucosal thickness with dilated congested thick wall blood vessels. The muscularis externa exhibited separated muscle fibers with the presence of mononuclear cell infiltration. TCs were ill-distinguished in the sections (Figures 3(i)–3(l)).

The UC+NC group revealed a similar structure to that of the control group with apparent preservation of intestinal crypts, goblet cells apart from dispersed inflammatory cell infiltrations in the lamina propria. However, small areas with discontinuous surface epithelium were still observed. TCs with long Tps can be seen in the sections (Figures 3(m)–3(p)).

3.2.2. Masson’s Trichrome Staining Results

The control and NC groups revealed regularly arranged fine collagen fibers in the submucosal layer and in between the crypts of the mucosa (Figures 4(a) and 4(b)). The UC group revealed a noticeable deposition of large amounts of collagen fibers in the mucosa. The submucosa exhibited collagen fibers separated by edema and congested blood vessels (Figure 4(c)). The UC+NC group had mild collagen fibers at the same sites (Figure 4(d)). A statistically significant increase was observed in the percent area of collagen fiber in the UC group compared with the control group with a significant decrease in the UC+NC group compared with the UC group (Figure 5).

3.3. Immunohistochemical Results

Immunostained sections from the colon of the control and NC group revealed numerous CD34+ and vimentin-positive TCs. The cells were cylindrical with thin, long Tps. In the mucosa, some TCs were observed in the lamina propria close to the crypt epithelium. TCs were also distributed among the smooth muscle cells of the muscularis mucosae. In the submucosa, TCs were distributed among collagen and elastic fibers in close contact with the blood vessels. In the muscularis propria, TCs were distributed among the smooth muscle bundles of the circular and longitudinal layers and surrounding the myenteric plexus. They were also found in the connective tissue and around the blood vessels of the subserosal layer (Figures 6(a)–6(f) and 7(a)–7(f)).

Figure 6

Photomicrographs of CD34 immunohistochemical stained sections in the colon. (a–c) The control group and (d-f) NC group both show numerous CD34 positive TCs (arrow) with long Tps (arrowhead) in the lamina propria close to the crypt epithelium, in between smooth muscle of muscularis mucosa, submucosa, between SMF of musculosa, in the myenteric plexus (star) and around blood vessels (BV). (g–i) The UC group reveals undetected TCs in the mucosa and submucosa. Few numbers of TCs are present in the musculosa and myenteric plexus (star). (j–l) The UC+NC group shows numerous TCs in all layers of the colon. Note: the endothelium of blood vessels (BV) reveals CD34 positive immune stain (CD34 immunostaining X400 insert in a and j X1000).

Figure 7

Photomicrographs of vimentin immunohistochemical-stained sections in the colon. (a–c) The control group and (d–f) NC group both show plentiful vimentin-positive TC cells (arrow) with long Tps (arrowhead) close to the crypt epithelium, muscularis mucosa, submucosa, musculosa, myenteric plexus, and around blood vessel (BV). (g–i) The UC group reveals hardly seen TCs in the mucosa and submucosa and few numbers of cells in the musculosa and myenteric plexus. (j–l) The UC+NC group shows abundant TCs in the mucosa, submucosa, musculosa, and myenteric plexus () (vimentin immunostaining X400 insert in k X1000).

CD34- and vimentin-stained sections from the UC group revealed that TCs were rarely detected in the mucosa and submucosal layers. The muscularis externa revealed few cells (Figures 6(g)–6(i) and 7(g)–7(i)). A significant decrease in numbers of TCs was observed in the UC group compared to controls (Figures 8(a) and 8(b)).

(a)

(b)

Figure 8

(a) Analysis of the number of CD 34 positive immune-stained TC/HPF in the study groups (6 rats/group). A: significant difference in relation to control group. B: significant difference in relation to NC group. C: significant difference in relation to UC group. (b) Analysis of the vimentin-positive immune-stained cells TC/HPF in the study groups (6 rats/group). A: significant difference in relation to control group. B: significant difference in relation to NC group. C: significant difference in relation to UC group.

The UC+NC-treated group revealed many CD34-positive TCs (Figures 6(j)–6(l)) and vimentin immune-stained cells (Figures 7(j)–7(l)) with similar distribution to that of the control group. A significant increase in the number of CD34 and vimentin immune-stained TCs was observed in comparison to the UC group, with no significant change when compared to controls (Figures 8(a) and 8(b)).

3.4. Semithin Section Results

Histological examination of toluidine blue staining of semithin sections from both the control (Figures 9(a)–9(c)) and NC groups (Figures 9(d)–9(f)) revealed numerous small cylindrical TCs with long Tps forming a reticulum around crypts, in the submucosa, and in contact with smooth muscle fibers, blood vessels, and the myenteric plexus. The UC group exhibited few TCs around the remnants of intestinal crypts, and these were completely absent within inflamed and fibrotic areas. TCs were rarely seen in the submucosa, muscularis externa, and around the myenteric plexus (Figures 9(g)–9(i)). The UC+NC group revealed frequent TCs in the mucosa surrounding the crypts, in the submucosa with close contact to mast cells, and in close proximity to muscle fibers and the myenteric plexus (Figures 9(j)–9(l)).

Figure 9

Photomicrographs of toluidine blue-stained semithin sections in the colon. (a–c) The control group and (d–f) NC group both show numerous TCs (arrow) with long Tps (arrowhead) around the intestinal crypts (C), in the submucosa, musculosa, and myenteric plexus (star). (g–i) The UC group reveals hardly seen TCs with short Tps round the remnant of crypts (C) and completely lost in inflamed areas (IC). Few TCs are hardly seen in the submucosa, the musculosa (MS), and myenteric plexus (star). (j–l) The UC+NC group shows numerous TCs with long Tps around the crypts (C) in the submucosa in contact with Mast cell (crossed arrow), the musculosa (MS), and myenteric plexus (star), (toluidine blue X400 insert in b and i X1000).

3.5. Molecular Results

The levels of mRNA gene expression of TNF-α, IL-6, and TGF-β revealed statistically significant increased expression in the UC group (, , and , respectively) compared to that of the control group (, , and , respectively) with values of 0.002, 0.022, and 0.005, respectively. No significant changes were observed between the UC+NC group and control groups. A statistically significant decrease in the expression of these three genes within the UC+NC group in comparison to the UC group was observed with values of < 0.001, 0.011, and 0.004, respectively (Figures 10 and 11(a)–11(c)).

(a)

(b)

(c)

(a)

(b)

(c)

Figure 11

(a) Analysis of IL-6 within the control and the experimental groups. A: significant difference in relation to control group. B: significant difference in relation to NC group. C: significant difference in relation to UC group. (b) Analysis of TNF alpha within the control and the experimental groups. A: significant difference in relation to control group. B: significant difference in relation to NC group. C: significant difference in relation to UC group. (c) Analysis of TG-β within the control and the experimental groups. A: significant difference in relation to control group. B: significant difference in relation to NC group. C: significant difference in relation to UC group.

4. Discussion

The use of nanotechnology in the treatment of gastrointestinal diseases has recently been taken under serious consideration, since it is one of the most promising delivery systems for curcumin in terms of overcoming the issue of limited bioavailability.

Considering the potential effects of curcumin, in this study, we attempted to elucidate the anti-inflammatory and fibrinolytic properties of curcumin nanoparticles in a rat model of UC and correlated these properties with histomorphometric changes in TCs.

We hypothesized that the administration of AA allows for and benefits experimental induction of inflammatory and fibrotic models of UC. In support, previous studies [22, 23] have recently reported that intracecal administration of AA is associated with increased gene expression of caspase-1, IL-B1, and the NLRP3 inflammasome, giving a typical picture of UC.

In the present study, microscopic examination of the colon mucosa in the UC group revealed a disturbed architecture in the form of mucosal ulceration, goblet cell depletion, dilated congested blood vessels, loss of crypts, thick muscularis mucosa, and excess inflammatory cell infiltration. Analysis of the submucosa revealed significant edema and inflammatory cell infiltration. Our results were in line with previous work [24, 25].

RT-PCR analysis revealed significant elevation of TNF-α and IL-6. In the context of UC, both TNF-α and IL-6 are particularly important. IL-6 is a proinflammatory and anti-inflammatory cytokine. Excess production of IL-6 is involved in the pathogenesis of IBD with consequent accumulation of T cells in the intestinal wall. In addition, excess release of cytokines may result in disturbed tight junctions and, consequently, intestinal barrier damage [26, 27].

TNF-α is a proinflammatory cytokine associated with increased levels of IL-1, which stimulates leukocyte migration to the site of inflammation and increases the levels of metalloproteinases in the matrix that is responsible for the destruction of the intestinal extracellular matrix [28]. TNF-α stimulates the release of oxidative inflammatory mediators even further than proinflammatory cytokine [28].

Histopathological examination of UC+NC-treated rats revealed preserved cytoarchitecture of the colonic mucosa with an obvious decrease in inflammatory cell infiltration. These histological results can be explained by the significant reduction of IL-6 and TNF-α gene expression in the nanocurcumin-treated group. Our results are in line with those previously reported [29], and they documented that curcumin exhibited a potential anti-inflammatory effect and downregulated proinflammatory mediators (i.e., NO, PGE2, TNF-α, and IL-6) through the inhibition of NF-κB and suppressed TLR4 activation.

Histological examination of Masson’s trichrome-stained sections of the UC group revealed a significant increase in collagen deposition in the mucosa and submucosa of acutely inflamed colons of the UC group compared to the control groups. This histological picture was confirmed by RT-PCR analysis of TGF-β, which revealed a significant increase compared to the control group. TGF-β stimulates collagen formation via myofibroblast activation [30].

A significant reduction in collagen deposition and submucosal thickness was observed in the UC+NC-treated group, and these results were confirmed by a significant decrease of TGF-β level in these rats when compared to the UC group. This result is in line with the data of a previous research work [31], and they reported that curcumin decreased both TGF-β and collagen I expression and could consequently prevent or postpone myofibrogenesis. In addition, nanocurcumin prompted myofibroblast apoptosis [32] and can prevent fibrosis by decreasing the expression of cytokine and chemokine genes that are directly implicated in fibrosis [33].

Telocytes have been recognized in many vertebrates within several different organs. Until now, the identification of TCs remains under debate and an association between these cells and other interstitial cells is common. However, light microscopic recognition of TCs depends on their ability to form 3D stromal networks via their long telopodes [34]. TCs express different immunological markers according to the organs in which they reside and the function performed by these cells [11]. Recently, CD34 and vimentin have been considered as reliable markers for the identification of TCs in the gut. CD34 is a transmembrane phosphoglycoprotein generally recognized in hematopoietic stem cells and vascular endothelial cells [35]. Some researchers refer to TCs as CD34+ stromal cells [36, 37]. Vimentin is an intermediate filament that is widely expressed in endothelial cells within blood vessels, epithelial cells, some vascular smooth muscle cells, cartilage, and bone cells. It is also responsible for providing structural support to the tissue [38].

Regarding the distribution of TCs in the colon of the control group, they were found to form an extensive network around the crypts and in the lamina propria. This arrangement ensures the maintenance of tissue integrity under stress from mechanical forces, such as distention and contraction [34]. In the muscularis mucosa and the musculosa, both CD34 and vimentin revealed TCs as positive immune-stained cells with their processes intermingled between muscle bundles and all around the myenteric plexus. This could explain the role of TCs in the regulation of gastrointestinal motility together with the interstitial cells of Cajal [39]. The distribution of TCs in the rat colon is in line with that described in the gut of the grass carp and other tubular organs in mammals [40].

In the UC group, TCs were significantly decreased, especially in inflamed or fibrotic areas. This could be due to the change in the composition of the extracellular matrix (ECM) and excess collagen fiber deposition, with the fibrotic extracellular matrix entrapping the TCs and leading to cell death as previously documented in cases of heart failure [41], scleroderma, and IBD [42]. Recently, a research work reported that the proliferative ability of TCs decreased with increasing levels of TNF-α [43], which is in line with our results.

TCs were reported to play an important role in the gastrointestinal tract (GIT). They have direct contact with various types of immune cells, including mast cells, dendritic cells, lymphocytes plasma cells, eosinophils, basophils, and macrophages [9, 40]. In line with the proposed role of TCs in the regulation of immune response through the paracrine pathway, TCs in the uterus were postulated to play a role in peritoneal macrophage activation. The activated macrophages revealed more pseudopodia and secreted different inflammatory cytokines including TNF-α, IL1-R1, and IL-10, indicating an impending role of TCs in the mechanism of immunoregulation and immunosurveillance [44].

TCs have been proposed to play a role in tissue shaping through the regulation of ECM formation during organ development. Regardless of the significant reduction of telocytes in UC preceding fibrosis or being a consequence of tissue fibrotic, loss of TCs might be a factor in the altered organization of ECM in the intestinal wall [39]. Additionally, contact between fibroblasts and TCs has been reported in many organs [9], indicating a role of TCs in tissue homeostasis through the regulation of fibroblastic activity via inhibitory signals [39].

Our results showed that the UC group was associated with frequent watery diarrhea as compared with well-formed pellets in the UC+NC-treated group. This could be due to a reduction in TC numbers which has a strategic position between the smooth muscle bundles; besides, the inflammation observed in the mucosa and increased IL-6 and TNF-α. Of note, close contact between TCs and crypts stem cells and the secretion of Wnt protein from subepithelial telocytes is particularly important in stem cell differentiation and epithelial renewal [10], which is in line with our results indicating that loss of subepithelial TCs in the UC group led to the failure of ulcer healing and epithelial regeneration.

Based on the results of this study, TCs play an important role in the pathogenesis of UC. In agreement with this hypothesis, TCs in the lamina propria of the GIT have been reported to secreted high levels of IL-6 and IL-10 in comparison to the surrounding stromal cells [10], indicating a potential role of TCs in the pathogenesis of inflammatory and immune-regulatory diseases.

Limitation of the study, further ultrastructural and immunological studies are required for better understand the role of TCs in the pathophysiology of ulcerative colitis. In this work, we study the effect of short-term curcumin treatment in the UC rat model, and long-term treatment with nanocurcumin in chronic or relapsing UC models should be considered in future researches.

5. Conclusion

To the best of our knowledge, no available studies have evaluated the effect of nanocurcumin on colon telocytes within UC. In the present study, immunohistochemical examination of the nanocurcumin-treated group revealed a significant increase in the TC count compared with the UC group and no significant changes when compared with the control group. This could be due to the anti-inflammatory and antifibrotic effects of nanocurcumin. These immunohistochemical results were in parallel with the molecular assessment of IL-6, TNF-α, and TGF-β.

These results are indicative of a pertinent role of nanocurcumin as a remedy for UC through its beneficial anti-inflammatory and fibrinolytic properties. This study also shed light on the role of TCs in the pathogenesis of UC and colonic tissue hemostasis. This information may be beneficial to researchers in the future who may consider using TCs in tissue repair and regeneration as a possible alternative of cell therapies.

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Ethical Approval

All experiments that involved animals strictly conformed to the animal experiment guidelines for the care and use of laboratory animals. The protocols of this study were approved by the Institutional Review Board of the Faculty of Medicine of Mansoura University (R.21.01.1153). Procedures were conformed to NIH (National Institutes of Health) Guidelines for the Care and Use of Laboratory Animals.

Conflicts of Interest

The authors declare that they have no conflict of interest.

References

P. Hindryckx, V. Jairath, and G. D’Haens, “Acute severe ulcerative colitis: from pathophysiology to clinical management,” Nature Reviews Gastroenterology & Hepatology, vol. 13, no. 11, pp. 654–664, 2016.
View at: Publisher Site | Google Scholar
A. Kaur and P. Goggolidou, “Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies,” Journal of Inflammation, vol. 17, no. 1, 2020.
View at: Publisher Site | Google Scholar
R. Mazieiro, R. R. Frizon, S. M. Barbalho, and R. D. Goulart, “Is curcumin a possibility to treat inflammatory bowel diseases?” Journal of Medicinal Food, vol. 21, no. 11, pp. 1077–1085, 2018.
View at: Publisher Site | Google Scholar
M. K. Gautam, S. Goel, R. R. Ghatule, A. Singh, G. Nath, and R. K. Goel, “Curative effect of Terminalia chebula extract on acetic acid-induced experimental colitis: role of antioxidants, free radicals and acute inflammatory marker,” Inflammopharmacology, vol. 21, no. 5, pp. 377–383, 2013.
View at: Publisher Site | Google Scholar
Y. Wang, C. E. Parker, T. Bhanji, B. G. Feagan, and J. K. MacDonald, “Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis,” The Cochrane Database of Systematic Reviews, vol. 4, no. 4, pp. CD000543–CD000543, 2016.
View at: Publisher Site | Google Scholar
G. Bassotti, E. Antonelli, V. Villanacci, M. Salemme, M. Coppola, and V. Annese, “Gastrointestinal motility disorders in inflammatory bowel diseases,” World Journal of Gastroenterology, vol. 20, no. 1, pp. 37–44, 2014.
View at: Publisher Site | Google Scholar
K. H. Kaestner, “The intestinal stem cell niche: a central role for Foxl1-expressing subepithelial telocytes,” Cellular and Molecular Gastroenterology and Hepatology, vol. 8, no. 1, pp. 111–117, 2019.
View at: Publisher Site | Google Scholar
E. A. Arafat, “Ultrastructural and immunohistochemical characteristics of telocytes in the skin and skeletal muscle of newborn rats,” Acta Histochemica, vol. 118, no. 6, pp. 574–580, 2016.
View at: Publisher Site | Google Scholar
L. Ceafalan, M. Gherghiceanu, L. M. Popescu, and O. Simionescu, “Telocytes in human skin--are they involved in skin regeneration?” Journal of Cellular and Molecular Medicine, vol. 16, no. 7, pp. 1405–1420, 2012.
View at: Publisher Site | Google Scholar
M. Gherghiceanu and L. M. Popescu, “Cardiac telocytes - their junctions and functional implications,” Cell and Tissue Research, vol. 348, no. 2, pp. 265–279, 2012.
View at: Publisher Site | Google Scholar
G. Greicius, Z. Kabiri, K. Sigmundsson et al., “PDGFRα(+) pericryptal stromal cells are the critical source of Wnts and RSPO3 for murine intestinal stem cells in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 14, pp. E3173–E3181, 2018.
View at: Publisher Site | Google Scholar
M. Shoshkes-Carmel, Y. J. Wang, K. J. Wangensteen et al., “Subepithelial telocytes are an important source of Wnts that supports intestinal crypts,” Nature, vol. 557, no. 7704, pp. 242–246, 2018.
View at: Publisher Site | Google Scholar
A. B. Kunnumakkara, D. Bordoloi, G. Padmavathi et al., “Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases,” British Journal of Pharmacology, vol. 174, no. 11, pp. 1325–1348, 2017.
View at: Publisher Site | Google Scholar
M. Ohno, A. Nishida, Y. Sugitani et al., “Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells,” PloS One, vol. 12, no. 10, pp. e0185999–e0185999, 2017.
View at: Publisher Site | Google Scholar
M. Masoodi, M. A. Mahdiabadi, M. Mokhtare et al., “The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients’ self-reported well-being: a randomized double-blind controlled trial,” Journal of Cellular Biochemistry, vol. 119, no. 11, pp. 9552–9559, 2018.
View at: Publisher Site | Google Scholar
F. Zabihi, N. Xin, J. Jia, T. Cheng, and Y. Zhao, “Preparation of nano-curcumin with enhanced dissolution using ultrasonic-assisted supercritical anti-solvent technique,” International Journal of Food Engineering, vol. 11, no. 5, pp. 609–617, 2015.
View at: Publisher Site | Google Scholar
G. Ercan, G. Yigitturk, and O. Erbas, “Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats,” Acta Cirurgica Brasileira, vol. 34, no. 12, pp. e201901204–e201901204, 2019.
View at: Publisher Site | Google Scholar
E. Küpeli Akkol, F. T. Gürağaç Dereli, H. Taştan, E. Sobarzo-Sánchez, and H. Khan, “Effect of _Sorbus domestica_ and its active constituents in an experimental model of colitis rats induced by acetic acid,” Journal of Ethnopharmacology, vol. 251, p. 112521, 2020.
View at: Publisher Site | Google Scholar
S. Kazemi-Darabadi, R. Nayebzadeh, A. A. Shahbazfar, F. Kazemi-Darabadi, and E. Fathi, “Curcumin and nanocurcumin oral supplementation improve muscle healing in a rat model of surgical muscle laceration,” Bulletin of Emergency and Trauma, vol. 7, no. 3, pp. 292–299, 2019.
View at: Publisher Site | Google Scholar
W. M. Freeman, S. J. Walker, and K. E. Vrana, “Quantitative RT-PCR: pitfalls and potential,” BioTechniques, vol. 26, no. 1, pp. 112–125, 1999.
View at: Publisher Site | Google Scholar
K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2^{−ΔΔ _C_}_T method,” Methods, vol. 25, no. 4, pp. 402–408, 2001.
View at: Publisher Site | Google Scholar
S. M. Abtahi Froushani and S. Mashouri, “The beneficial effects of hypiran in ameliorating rat model of ulcerative colitis,” Zahedan Journal of Research in Medical Sciences, vol. 20, no. 1, 2018.
View at: Publisher Site | Google Scholar
N. A. Soliman, W. A. Keshk, F. H. Rizk, and M. A. Ibrahim, “The possible ameliorative effect of simvastatin versus sulfasalazine on acetic acid induced ulcerative colitis in adult rats,” Chemico-Biological Interactions, vol. 298, pp. 57–65, 2019.
View at: Publisher Site | Google Scholar
G. Owusu, D. D. Obiri, G. K. Ainooson et al., “Acetic acid-induced ulcerative colitis in Sprague Dawley rats is suppressed by hydroethanolic extract of Cordia vignei leaves through reduced serum levels of TNF-α and IL-6,” International Journal of Chronic Diseases, vol. 2020, 8785411 pages, 2020.
View at: Publisher Site | Google Scholar
X. Xu, S. Lin, Y. Yang et al., “Histological and ultrastructural changes of the colon in dextran sodium sulfate-induced mouse colitis,” Experimental and Therapeutic Medicine, vol. 20, no. 3, pp. 1987–1994, 2020.
View at: Publisher Site | Google Scholar
R. Atreya, J. Mudter, S. Finotto et al., “Blockade of interleukin 6 _trans_ signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis _in vivo_,” Nature Medicine, vol. 6, no. 5, pp. 583–588, 2000.
View at: Publisher Site | Google Scholar
C. Romagnoli, S. Frezza, A. Cingolani et al., “Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis,” European Journal of Pediatrics, vol. 160, no. 6, pp. 345–350, 2001.
View at: Publisher Site | Google Scholar
S. L. F. Pender, C. Braegger, U. Günther et al., “Matrix metalloproteinases in necrotising enterocolitis,” Pediatric Research, vol. 54, no. 2, pp. 160–164, 2003.
View at: Publisher Site | Google Scholar
A. Lubbad, M. A. Oriowo, and I. Khan, “Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis,” Molecular and Cellular Biochemistry, vol. 322, no. 1–2, pp. 127–135, 2009.
View at: Publisher Site | Google Scholar
E. R. García-Trevijano, M. J. Iraburu, L. Fontana et al., “Transforming growth factor β1induces the expression of α1(i) procollagen mRNA by a hydrogen peroxide-C/EBPβ-dependent mechanism in rat hepatic stellate cells,” Hepatology, vol. 29, no. 3, pp. 960–970, 1999.
View at: Publisher Site | Google Scholar
A. Saidi, M. Kasabova, L. Vanderlynden et al., “Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and L,” Scientific Reports, vol. 9, no. 1, p. 491, 2019.
View at: Publisher Site | Google Scholar
S. Bisht, M. A. Khan, M. Bekhit et al., “A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl₄-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation,” Laboratory Investigation; a Journal of Technical Methods and Pathology, vol. 91, no. 9, pp. 1383–1395, 2011.
View at: Publisher Site | Google Scholar
A. Karthikeyan, N. Senthil, and T. Min, “Nanocurcumin: a promising candidate for therapeutic applications,” Frontiers in Pharmacology, vol. 11, p. 487, 2020.
View at: Publisher Site | Google Scholar
D. Cretoiu, M. Giuliana Vannucchi, Y. Bei et al., “Telocytes: new connecting devices in the stromal space of organs,” in Innovations in Cell Research and Therapy, IntechOpen, 2020.
View at: Publisher Site | Google Scholar
F. M. Abdel-Maksoud, H. H. Abd-Elhafeez, and S. A. Soliman, “Morphological changes of telocytes in camel efferent ductules in response to seasonal variations during the reproductive cycle,” Scientific Reports, vol. 9, no. 1, p. 4507, 2019.
View at: Publisher Site | Google Scholar
L. Díaz-Flores, R. Gutiérrez, M. P. García et al., “Uptake and intracytoplasmic storage of pigmented particles by human CD34+ stromal cells/telocytes: endocytic property of telocytes,” Journal of Cellular and Molecular Medicine, vol. 18, no. 12, pp. 2478–2487, 2014.
View at: Publisher Site | Google Scholar
M. Marini, M. Manetti, I. Rosa, L. Ibba-Manneschi, and E. Sgambati, “Telocytes in human fetal skeletal muscle interstitium during early myogenesis,” Acta Histochemica, vol. 120, no. 5, pp. 397–404, 2018.
View at: Publisher Site | Google Scholar
A. Satelli and S. Li, “Vimentin in cancer and its potential as a molecular target for cancer therapy,” Cellular and Molecular Life Sciences : CMLS, vol. 68, no. 18, pp. 3033–3046, 2011.
View at: Publisher Site | Google Scholar
L. Ibba-Manneschi, I. Rosa, and M. Manetti, “Telocyte implications in human pathology: an overview,” Seminars in Cell & Developmental Biology, vol. 55, pp. 62–69, 2016.
View at: Publisher Site | Google Scholar
H. H. Abd-Elhafeez, A. S. Abou-Elhamd, and S. A. Soliman, “Morphological and immunohistochemical phenotype of TCs in the intestinal bulb of grass carp and their potential role in intestinal immunity,” Scientific Reports, vol. 10, no. 1, p. 14039, 2020.
View at: Publisher Site | Google Scholar
M. Richter and S. Kostin, “The failing human heart is characterized by decreased numbers of telocytes as result of apoptosis and altered extracellular matrix composition,” Journal of Cellular and Molecular Medicine, vol. 19, no. 11, pp. 2597–2606, 2015.
View at: Publisher Site | Google Scholar
M. Manetti, I. Rosa, L. Messerini, and L. Ibba-Manneschi, “Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis,” Journal of Cellular and Molecular Medicine, vol. 19, no. 1, pp. 62–73, 2015.
View at: Publisher Site | Google Scholar
D. Song, M. Xu, R. Qi et al., “Influence of gene modification in biological behaviors and responses of mouse lung telocytes to inflammation,” Journal of Translational Medicine, vol. 17, no. 1, p. 158, 2019.
View at: Publisher Site | Google Scholar
C. Chi, X.-J. Jiang, L. Su, Z.-J. Shen, and X.-J. Yang, “In vitro morphology, viability and cytokine secretion of uterine telocyte- activated mouse peritoneal macrophages,” Journal of Cellular and Molecular Medicine, vol. 19, no. 12, pp. 2741–2750, 2015.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Eetmad A. Arafat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

648

Downloads

761

Citations